Updated:
Viola Ventures
Shlomo Dovrat co-founded Viola Ventures in 1999, building an Israeli multi-stage VC managing ~$2B across enterprise software, AI, cybersecurity, and fintech.
Viola Ventures
VIOLA VENTURES MANAGEMENT (2017) LIMITED PARTNERSHIP is a 2017 Tel Aviv-based investment adviser registered with the SEC since 2018.
General information
Firm type
Venture Capital
Year founded
1999
AUM
$2B to $3B (per public record)
Location
Region
Middle East
Country
Israel
City
Tel Aviv
Corporate office
Tel Aviv, Israel
Additional offices
Herzliya, Israel
Principals
Shlomo Dovrat
General Partner
Ayal Itzkovitz
General Partner
Yehoshua (Shuki) Amrani
General Partner
Rona Segev
General Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Viola Ventures?
Investment decisions are made by the firm's four general partners: Shlomo Dovrat, Ayal Itzkovitz, Yehoshua (Shuki) Amrani, and Rona Segev. Each general partner focuses on specific verticals and stages; Dovrat and Itzkovitz lead the early-stage activity while Amrani and Segev cover growth opportunities.
What is the relationship between Viola Ventures and the Viola Group?
Viola Ventures is the early-stage venture arm of the Viola Group, a multi-asset Israeli investment platform that also manages Viola Growth (later-stage tech), Viola Credit (private credit), and Viola Fintech. The group structure allows Viola Ventures to offer portfolio companies follow-on capital from its sister funds without requiring external partners.
Does Viola Ventures participate in fund commitments or only direct deals?
Viola Ventures primarily makes direct equity investments in technology companies. It also acts as a limited partner in select venture funds globally, though direct deals account for the vast majority of its deployed capital.
What investment stages does Viola Ventures typically target?
The firm targets seed, Series A, and growth-stage investments in technology companies. While its earliest investments are typically at seed, the firm has increasingly focused on Series A and B rounds as its portfolio matured.
Which sectors does Viola Ventures explicitly avoid?
Viola Ventures does not invest in biotech or pharmaceuticals, nor in pure hardware companies. Its focus is on software, data, AI, and services that can scale globally from an Israel base.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: